These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2202199)

  • 1. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
    D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G
    Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.
    d'Albasio G; Paoluzi P; Campieri M; Bianchi Porro G; Pera A; Prantera C; Sturniolo GC; Miglioli M
    Am J Gastroenterol; 1998 May; 93(5):799-803. PubMed ID: 9625131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].
    Ngô Y; Gélinet JM; Ivanovic A; Kac J; Schénowitz G; Vilotte J; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(10):782-6. PubMed ID: 1478406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.
    Campieri M; De Franchis R; Bianchi Porro G; Ranzi T; Brunetti G; Barbara L
    Scand J Gastroenterol; 1990 Jul; 25(7):663-8. PubMed ID: 2204103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
    d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
    Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
    Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M
    Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P
    Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis.
    LaRosa D; Rubin PH; Bodian C; Present DH
    Am J Gastroenterol; 1991 Oct; 86(10):1456-60. PubMed ID: 1681725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.
    Guarino J; Chatzinoff M; Berk T; Friedman LS
    Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
    Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G
    Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.
    Bardazzi G; d'Albasio G; Bonanomi AG; Trallori G; Messori A; Amorosi A; Bartoletti L; Morettini A; Pacini F
    Ital J Gastroenterol; 1994 Sep; 26(7):334-7. PubMed ID: 7812025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.
    Casellas F; Vaquero E; Armengol JR; Malagelada JR
    Hepatogastroenterology; 1999; 46(28):2343-6. PubMed ID: 10521994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Brunetti G; Miglioli M; Barbara L
    Int J Colorectal Dis; 1990 May; 5(2):79-81. PubMed ID: 2193075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
    Freund U; Schölmerich J; Siems H; Kluge F; Schäfer HE; Wannenmacher M
    Strahlenther Onkol; 1987 Oct; 163(10):678-80. PubMed ID: 3313776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminosalicylic acid suppositories in the management of ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Torresan F; Tampieri M; Iannone P; Miglioli M; Barbara L
    Dis Colon Rectum; 1989 May; 32(5):398-9. PubMed ID: 2714131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
    Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.